Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,815,885
+$18,029 QoQ
Shares Held
7,150
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#2,433
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOK Financial Private Wealth, Inc. holds $4,582,114 across 15 Drug Manufacturers - General names. JNJ ranks #1 (39.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
7,150 | $1,815,885 | |
| 2 | LLY |
ELI LILLY & Co
|
743 | $891,176 | |
| 3 | ABBV |
AbbVie Inc.
|
2,766 | $696,036 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,043 | $519,525 | |
| 5 | PFE |
Pfizer Inc
|
8,084 | $194,662 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,482 | $143,012 | |
| 7 | NVO |
Novo Nordisk A S
|
2,829 | $135,622 | |
| 8 | GSK |
GSK plc
|
1,786 | $93,622 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,815,885 | 7,150 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,797,856 | 7,355 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,591,652 | 7,691 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,569,765 | 8,466 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,010,953 | 13,165 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,444,134 | 8,708 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,693,934 | 11,713 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,057,027 | 12,693 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,342,333 | 9,184 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,915,758 | 18,432 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,108,312 | 26,211 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $4,461,770 | 28,647 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $5,559,982 | 33,591 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,084,060 | 39,252 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,791,839 | 38,448 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $7,047,187 | 43,139 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,160,398 | 40,338 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,986,024 | 56,345 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,257,110 | 54,113 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $7,633,620 | 47,267 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,629,438 | 46,312 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $7,203,296 | 43,829 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,796,297 | 43,184 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,235,689 | 41,884 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $6,187,157 | 43,996 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,490,276 | 57,121 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||